|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 445.2 USD | +1.04% |
|
+5.31% | +9.42% |
| May. 15 | Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director | CI |
| May. 14 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
Vertex Pharmaceuticals Incorporated re-iterated earnings guidance for the full year 2024. For the period, Company expects product revenue guidance of $10.55 to $10.75 billion.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B | |
| -24.95% | 8.23B |
VERTEX PHARMACEUTICALS INCORPORATED 
